Natco Pharma has applied for the country's first compulsory licence to sell a generic version of Bayer's patented medicine.

Pharma powerhouse Cipla has started talks with the government to share knowledge on making cancer drugs, which, if successful, could radica...

Cipla has launched a copycat version of German pharma company Bayer’s cancer medicine Nexavar at one-tenth the price.

The Delhi HC dismissed an appeal by German drugmaker Bayer that sought to stop Cipla from obtaining a marketing approval from the country’s...

Maharashtra may set its foot where almost no state government has ventured so far and where even the Centre fears to tread.

On January 25 this year, the patent office in Chennai rejected a patent application by pharma MNC Novartis for its anti-cancer drug Glivec ...